ACT KNOW , the first randomised controlled trial ever performed in knowlesi malaria , is a two-arm open-label trial with enrolments over a 2-year period at three district sites in Sabah , powered to show a difference in proportion of patients negative for malaria by microscopy at 24h between treatment arms ( clinicaltrials.gov #NCT 01708876 ) .